Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET.
| Image |  |
|---|---|
| Description | scientific article published on 20 June 2012 |
| Author/s |
author: Matthias Scheffler Bernd Neumaier |
| Publication date | June 20, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |